Table 1.
Clinical details from evaluated FTLD-TDP cases
| Type | Family History |
Mutation | Sex | Age | Onset | Duration | Brain Weight (g) |
|---|---|---|---|---|---|---|---|
| A | + | F | 64 | 59 | 5 | 880 | |
| A | + | M | 68 | 62 | 6 | 1040 | |
| A | + | GRN | M | 69 | 62 | 7 | 1000 |
| B | U | F | 58 | U | U | 1110 | |
| B | + | F | 54 | 49 | 5 | 1100 | |
| B | − | F | 85 | 82 | 3 | 980 | |
| B | − | M | 49 | 44 | 5 | 1188 | |
| B | U | M | 67 | 61 | 6 | 1140 | |
| C | − | F | 65 | 53 | 12 | 990 | |
| C | + | F | 81 | 68 | 13 | 1040 |
Age age at death, Duration length of disease course, Family History other affected family members with FTLD-TDP, GRN progranulin gene, Mutation identified genetic cause of FTLD-TDP, Onset age at diagnosis of FTLD, Type harmonized FTLD-TDP classification [37], U unknown, + positive, − negative